Burjeel-Aasandha Partnership Brings Complex Care Closer to Maldivians, Boosts Medical Tourism in Abu Dhabi.
The collaboration will provide Maldivian patients access to specialized medical care, including multi-organ transplants, oncology, and endometriosis treatments, at the Group’s flagship facility Burjeel Medical City.
This partnership will significantly strengthen the healthcare ties between the UAE and the Maldives,attracting more international patients seeking world-class treatments.
Abu Dhabi, December 11, 2024: In a significant move to strengthen medical tourism ties and broaden
healthcare options for Maldivians, Burjeel Holdings, a leading super-specialty healthcare provider in the
MENA region, listed on the Abu Dhabi Securities Exchange, has partnered with Aasandha Company Ltd,
the administrator of the Maldives’ National Social Health Insurance Scheme. This strategic partnership
opens the doors for Maldivian patients to access advanced medical treatments, including multi-organ
transplants and complex medical care in key specialties including oncology, at Burjeel Medical City
(BMC), the Group’s flagship quaternary hospital in Abu Dhabi.
The collaboration agreement was signed at Aasandha Headquarters in Male by Mr. John Sunil, Group
CEO of Burjeel Holdings, and Ms. Aminath Zeeniya, Managing Director/CEO of Aasandha, in the
presence of senior officials from both organizations.
A Hub for Complex Care
This collaboration provides the patients covered under the Maldives’ National Social Health Insurance
Scheme with access to advanced care across specialties like cardiology and advanced orthopedics, and
treatments for conditions like endometriosis at BMC, a growing hub for international patients in the region.
Most notably, Maldivian patients now have access to life-saving transplant services, a critical addition to
their healthcare options.
Mr. John Sunil, Group CEO of Burjeel Holdings, said, “This collaboration reflects our commitment to
bridging healthcare gaps and extending our expertise beyond borders, underscoring Abu Dhabi’s growing
status as a global hub for medical excellence. We are honored to provide Maldivian patients with access
to advanced care, cutting-edge technology and renowned specialists at BMC.”
Boosting Medical Tourism
Abu Dhabi’s strategic location as a gateway to Europe, Asia, and Africa positions it as a prime destination
for international healthcare. With direct flights from Abu Dhabi to Male taking just over four hours, the
Emirate offers Maldivians convenient access to advanced medical care. This collaboration not only
enhances healthcare accessibility but also significantly boosts medical tourism between the UAE and the
Maldives, attracting more international patients seeking world-class treatments.
This partnership streamlines the care journey for Maldivian patients through an efficient pre-authorization
process and dedicated international patient coordinators. At BMC, patients benefit from a full spectrum of
inpatient and outpatient services, state-of-the-art technology, internationally accredited standards, and a
multidisciplinary approach to managing complex medical conditions. This comprehensive care model
ensures Maldivians receive a seamless, high-quality healthcare experience in Abu Dhabi.
Ms. Aminath Zeeniya, Managing Director/CEO of Aasandha, said, “We are delighted to collaborate
with Burjeel Holdings to enhance the healthcare options available to Maldivians. This partnership ensures
our citizens can access the best treatments in a world-class facility, strengthening the Maldives’ National
Social Health Insurance Scheme.”
Aasandha Company Ltd, established in 2011, provides comprehensive healthcare services to all
Maldivian citizens. Funded by the government, the insurance scheme covers inpatient, outpatient, and
emergency services, as well as medical care abroad. Through this partnership with Burjeel, Aasandha
expands its ability to offer Maldivians high-end treatments like organ transplants and other specialized
services.(Ends)-—-